Pharmacology of carbon nanotubes: Toxicokinetics, excretion and tissue accumulation

Advanced Drug Delivery Reviews

Volumn 65, Issue 15, 2013, Pages 2111-2119

  Ali Boucetta, Hanene ^a   Kostarelos, Kostas ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biodistribution; Carbon nanotubes; CNT; Functionalisation; Nanotoxicology; Toxicokinetics

Indexed keywords

BIODISTRIBUTIONS; CNT; FUNCTIONALISATION; NANOTOXICOLOGY; TOXICOKINETICS;

MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; PHARMACOKINETICS; TISSUE;

CARBON NANOTUBES;

CARBON NANOTUBE; GLUCOSAMINE; INDIUM 111; MACROGOL; MULTI WALLED NANOTUBE; PENTETIC ACID; QUANTUM DOT; RITUXIMAB; SINGLE WALLED NANOTUBE; TAURINE; TECHNETIUM 99M; TETRAXETAN;

BINDING AFFINITY; BIOACCUMULATION; CHEMICAL MODIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; DISPERSION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; EXCRETION; EXPOSURE; ISOTOPE LABELING; NANOTOXICOLOGY; PHYSICAL CHEMISTRY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; SYSTEMIC CIRCULATION; TISSUE DISTRIBUTION; TOXICOKINETICS;

BIODISTRIBUTION; CARBON NANOTUBES; CNT; FUNCTIONALISATION; NANOTOXICOLOGY; TOXICOKINETICS;

ANIMALS; HUMANS; LUNG; NANOMEDICINE; NANOTUBES, CARBON; PHARMACOKINETICS; SKIN; TISSUE DISTRIBUTION;

EID: 84888860279     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.10.004     Document Type: Review

References (60)

1. Ali-Boucetta H., Al-Jamal K.T., McCarthy D., Prato M., Bianco A., Kostarelos K. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem. Commun. 2008, 459-461.
2. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalised carbon nanotubes. Chem. Commun. 2005, 5:571-577.
3. Hong S.Y., Tobias G., Al-Jamal K.T., Ballesteros B., Ali-Boucetta H., Lozano-Perez S., Nellist P.D., Sim R.B., Finucane C., Mather S.J., Green M.L.H., Kostarelos K., Davis B.G. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat. Mater. 2010, 9:485-490.
4. Kostarelos K. Carbon nanotubes: fibrillar pharmacology. Nat. Mater. 2010, 9:793-795.
5. Kostarelos K., Bianco A., Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 2009, 4:627-633.
6. Podesta J., Al-Jamal T.K., Herrero M.A., Tian B., Ali-Boucetta H., Hegde V., Bianco A., Prato M., Kostarelos K. Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small 2009, 1176-1185.
7. Lacerda L., Herrero M.A., Venner K., Bianco A., Prato M., Kostarelos K. Carbon-nanotube shape and individualization critical for renal excretion. Small 2008, 4:1130-1132.
8. Al-Jamal K.T., Nunes A., Methven L., Ali-Boucetta H., Li S., Toma F.M., Herrero M.A., Al-Jamal W.T., ten Eikelder H.M.M., Foster J., Mather S., Prato M., Bianco A., Kostarelos K. Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile. Angew. Chem. Int. Ed. 2012, 51:6389-6393.
9. McDevitt M.R., Chattopadhyay D., Jaggi J.S., Finn R.D., Zanzonico P.B., Villa C., Rey D., Mendenhall J., Batt C.A., Njardarson J.T., Scheinberg D.A. PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS One 2007, 2:e907.
10. McDevitt M.R., Chattopadhyay D., Kappel B.J., Jaggi J.S., Schiffman S.R., Antczak C., Njardarson J.T., Brentjens R., Scheinberg D.A. Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl. Med. 2007, 48:1180-1189.
11. Liu Z., Davis C., Cai W., He L., Chen X., Dai H. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1410-1415.
12. El-Sayed R., Eita M., Barrefelt Å., Ye F., Jain H., Fares M., Lundin A., Crona M., Abu-Salah K., Muhammed M., Hassan M. Thermostable luciferase from Luciola cruciate for imaging of carbon nanotubes and carbon nanotubes carrying doxorubicin using in vivo imaging system. Nano Lett. 2013, 13:1393-1398.
13. Bianco A., Kostarelos K., Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem. Commun. 2011, 47.
14. Samorì C., Ali-Boucetta H., Sainz R., Guo C., Toma F.M., Fabbro C., da Ros T., Prato M., Kostarelos K., Bianco A. Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers. Chem. Commun. 2010, 46:1494-1496.
15. Kam N.W.S., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11600-11605.
16. Cherukuri P., Gannon C.J., Leeuw T.K., Schmidt H.K., Smalley R.E., Curley S.A., Weisman R.B. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18882-18886.
17. Yang S.-t., Guo W., Lin Y., Deng X.-y., Wang H.-f., Sun H.-f., Liu Y.-f., Wang X., Wang W., Chen M., Huang Y.-p., Sun Y.-P. Biodistribution of pristine single-walled carbon nanotubes in vivo. J. Phys. Chem. C 2007, 111:17761-17764.
18. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., Chen X., Dai H. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2007, 2:47-52.
19. Prencipe G., Tabakman S.M., Welsher K., Liu Z., Goodwin A.P., Zhang L., Henry J., Dai H. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J. Am. Chem. Soc. 2009, 131:4783-4787.
20. Liu X., Tao H., Yang K., Zhang S., Lee S.-T., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
21. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., Bianco A., Kostarelos K. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3357-3362.
22. Guo J., Zhang X., Li Q., Li W. Biodistribution of functionalized multiwall carbon nanotubes in mice. Nucl. Med. Biol. 2007, 34:579-583.
23. Wang H., Wang J., Deng X., Sun H., Shi Z., Gu Z., Liu Y., Zhao Y. Biodistribution of carbon single-wall carbon nanotubes in mice. J. Nanosci. Nanotechnol. 2004, 4:1019-1024.
24. Deng X., Jia G., Wang H., Sun H., Wang X., Yang S., Wang T., Liu Y. Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon 2007, 45:1419-1424.
25. Wang J., Deng X., Yang S., Wang H., Zhao Y., Liu Y. Rapid translocation and pharmacokinetics of hydroxylated single-walled carbon nanotubes in mice. Nanotoxicology 2008, 2:28-32.
26. Deng X., Yang S., Nie H., Wang H., Liu Y. A generally adoptable radiotracing method for tracking carbon nanotubes in animals. Nanotechnology 2008, 19:075101.
27. Yang S.T., Shiral Fernando K.A., Liu J.-H., Wang J., Sun H.-F., Liu Y., Chen M., Huang Y., Wang X., Wang H., Sun Y.-P. Covalently PEGylated carbon nanotubes with stealth character in vivo. Small 2008, 4:940-944.
28. Lacerda L., Soundararajan A., Pastorin G., Al-Jamal K., Herrero M.A., Bao A., Emfietzoglou D., Mather S., Phillips W.T., Prato M., Bianco A., Goins B., Kostarelos K. Dynamic imaging of functionalised multi-walled carbon nanotube systemic circulation & urinary excretion. Adv. Mater. 2008, 20(2):225-230.
29. Lacerda L., Ali-Boucetta H., Herrero M.A., Pastorin G., Bianco A., Prato M., Kostarelos K. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomedicine 2008, 3:149-161.
30. Ruggiero A., Villa C.H., Bander E., Rey D.A., Bergkvist M., Batt C.A., Manova-Todorova K., Deen W.M., Scheinberg D.A., McDevitt M.R. Paradoxical glomerular filtration of carbon nanotubes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12369-12374.
31. Jain S., Thakare V.S., Das M., Godugu C., Jain A.K., Mathur R., Chuttani K., Mishra A.K. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density. Chem. Res. Toxicol. 2011, 24:2028-2039.
32. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 2011, 6:715-728.
33. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68:6652-6660.
34. Liu Z., Sun X., Nakayama-Ratchford N., Dai H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 2007, 1:50-56.
35. Bhirde A.A., Patel S., Sousa A.A., Patel V., Molinolo A.A., Ji Y., Leapman R.D., Gutkind J.S., Rusling J.F. Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine 2010, 5:1535-1546.
36. Zhang D., Deng X., Ji Z., Shen X., Dong L., Wu M., Gu T., Liu Y. Long-term hepatotoxicity of polyethylene-glycol functionalized multi-walled carbon nanotubes in mice. Nanotechnology 2010, 21:1-10.
37. Yang S.-T., Wang Y.-W., Liu J.-H., Wang H. Biodistribution of multi-walled carbon nanotubes functionalized by hydroxyl terminated poly(ethylene glycol) in mice. J. Radioanal. Nucl. Chem. 2013, 295:1181-1186.
38. Yang S.-T., Fernando K.A.S., Liu J.-H., Wang J., Sun H.-F., Liu Y., Chen M., Huang Y., Wang X., Wang H., Sun Y.-P. Covalently PEGylated carbon nanotubes with stealth character in vivo. Small 2008, 4:940-944.
39. Faure A.-C., Dufort S., Josserand V., Perriat P., Coll J.-L., Roux S., Tillement O. Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small 2009, 5:2565-2575.
40. Murphy F.A., Poland C.A., Duffin R., Al-Jamal K.T., Ali-Boucetta H., Nunes A., Byrne F., Prina-Mello A., Volkov Y., Li S., Mather S.J., Bianco A., Prato M., MacNee W., Wallace W.A., Kostarelos K., Donaldson K. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 2011, 178:2587-2600.
41. Sato Y., Yokoyama A., Shibata K., Akimoto Y., Ogino S., Nodasaka Y., Kohgo T., Tamura K., Akasaka T., Uo M., Motomiya K., Jeyadevan B., Ishiguro M., Hatakeyama R., Watari F., Tohji K. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol. Biosyst. 2005, 1:176-182.
42. Koyama S., Kim Y.A., Hayashi T., Takeuchi K., Fujii C., Kuroiwa N., Koyama H., Tsukahara T., Endo M. In vivo immunological toxicity in mice of carbon nanotubes with impurities. Carbon 2009, 47:1365-1372.
43. Carrero-Sanchez J.C., Elias A.L., Mancilla R., Arrellin G., Terrones H., Laclette J.P., Terrones M. Biocompatibility and toxicological studies of carbon nanotubes doped with nitrogen. Nano Lett. 2006, 6:1609-1616.
44. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinsky T., Radomski M. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 2005, 146:882-893.
45. Schipper M.L., Nakayama-Ratchford N., Davis C.R., Kam N.W.S., Chu P., Liu Z., Sun X., Dai H., Gambhir S.S. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 2008, 3:216-221.
46. Yang S.T., Wang X., Jia G., Gu Y., Wang T., Nie H., Ge C., Wang H., Liu Y. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett. 2008, 181:182-189.
47. Deng X., Wu F., Liu Z., Luo M., Li L., Ni Q., Jiao Z., Wu M., Liu Y. The splenic toxicity of water soluble multi-walled carbon nanotubes in mice. Carbon 2009, 47:1421-1428.
48. Maynard A.D., Baron P.A., Foley M., Shvedova A.A., Kisin E.R., Castranova V. Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J. Toxicol. Environ. Health A 2004, 67:87-107.
49. Li J.G., Li W.X., Xu J.Y., Cai X.Q., Liu R.L., Li Y.J., Zhao Q.F., Li Q.N. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ. Toxicol. 2007, 22:415-421.
50. Mitchell L.A., Gao J., Wal R.V., Gigliotti A., Burchiel S.W., McDonald J.D. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol. Sci. 2007, 100:203-214.
51. Mitchell L.A., Lauer F.T., Burchiel S.W., McDonald J.D. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat. Nanotechnol. 2009, 4:451-456.
52. Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A.M., Webb T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 2004, 77:117-125.
53. Lam C.W., James J.T., McCluskey R., Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90days after intratracheal instillation. Toxicol. Sci. 2004, 77:126-134.
54. Huczko A., Lange H., Calko E., Grubek-Jaworska H., Droszcz P. Physiological testing of carbon nanotubes: are they asbestos-like?. Fuller. Sci. Technol. 2001, 9:251-254.
55. Huczko A., Lange H., Bystrzejewski M., Baranowski P., Grubek-Jaworska H., Nejman P., Przybylowski T., Czuminska K., Glapinski J., Walton D.R.M., Kroto H.W. Pulmonary toxicity of 1-D nanocarbon materials. Fuller. Nanotubes Carbon Nanostruct. 2005, 13:141-145.
56. Elgrabli D., Abella-Gallart S., Robidel F., Rogerieux F., Boczkowski J., Lacroix G. Induction of apoptosis and absence of inflammation in rat lung after intratracheal instillation of multiwalled carbon nanotubes. Toxicology 2008, 253:131-136.
57. Li Z., Hulderman T., Salmen R., Chapman R., Leonard S.S., Young S.H., Shvedova A., Luster M.I., Simeonova P.P. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ. Health Perspect. 2007, 115:377-382.
58. Erdely A., Hulderman T., Salmen R., Liston A., Zeidler-Erdely P.C., Schwegler-Berry D., Castranova V., Koyama S., Kim Y.-A., Endo M., Simeonova P.P. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 2009, 9:36-43.
59. Huczko A., Lange H. Carbon nanotubes: experimental evidence for a null risk of skin irritation and allergy. Fuller. Sci. Technol. 2001, 9:247-250.
60. Robinson J.T., Hong G., Liang Y., Zhang B., Yaghi O.K., Dai H. In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake. J. Am. Chem. Soc. 2012, 134:10664-10669.